Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs AHR✓SelectedUSD · AHRGSK vs AHR performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs AHR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+29.8%
AHR return
+400.8%
Excess return
-371.0%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioAHRExcessAlpha
1D-1.3%+1.1%-2.4%-1.5%
7D-3.1%-1.1%-2.0%-2.9%
30D-0.9%+11.6%-12.5%-2.7%
3M-4.2%+8.1%-12.3%-5.4%
6M-1.6%+18.0%-19.6%-4.1%
YTD+2.6%+26.3%-23.7%-1.0%
1Y+6.2%+21.5%-15.3%+3.0%
All+29.8%+400.8%-371.0%+4.1%

Cumulative growth

Daily Returns

Daily percentage return beside AHR.

Daily Out/Under-Performance

Portfolio return minus AHR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × AHR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded AHR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling